TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients.
about
Tumor Heterogeneity, Single-Cell Sequencing, and Drug ResistanceStem cell technology in breast cancer: current status and potential applicationsEvaluation and consequences of heterogeneity in the circulating tumor cell compartmentCirculating tumor cells in breast cancerNotes for developing a molecular test for the full characterization of circulating tumor cellsTumour Heterogeneity: The Key Advantages of Single-Cell AnalysisDissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the HaystackMicrofluidic Sample Preparation for Single Cell Analysis.Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis.Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients.Evaluation of a novel approach to circulating tumor cell isolation for cancer gene panel analysis in patients with breast cancer.Cancer gene panel analysis of cultured circulating tumor cells and primary tumor tissue from patients with breast cancer.EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation.Heterogeneity of miR-10b expression in circulating tumor cellsArterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma CellsAnalysis of tumor template from multiple compartments in a blood sample provides complementary access to peripheral tumor biomarkersBreast cancer circulating biomarkers: advantages, drawbacks, and new insights.Single circulating tumor cell sequencing as an advanced tool in cancer management.Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine.Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution.The Role of BEAMing and Digital PCR for Multiplexed Analysis in Molecular Oncology in the Era of Next-Generation Sequencing.Single-cell profiling approaches to probing tumor heterogeneity.A headlight on liquid biopsies: a challenging tool for breast cancer management.Ex vivo culture of circulating tumor cells using magnetic force-based coculture on a fibroblast feeder layer.Circulating tumor cell technologies.Clinical Outcomes of TP53 Mutations in Cancers.Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer.Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.Circulating tumor cells: silent predictors of metastasis.Application of single-cell sequencing in human cancer.Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.Improving the CellSearch® system.Cancer panel analysis of circulating tumor cells in patients with breast cancer.
P2860
Q26744341-0EB6DC97-CD49-4C5A-B649-F7E1A0CF2A94Q26746223-EF3616FA-F7BF-4458-B124-1F69DD1B3D96Q26765357-B9D72A30-0FF5-4158-90A1-019A5E02B979Q26774808-4DE7BB3E-2352-422A-AACC-9E9A1EF064F6Q26778913-FB2BAD2A-B6DB-4A0D-97BD-04C05934E995Q28066914-0C5C7E1D-C9CD-4006-8B3E-555D4D6DF401Q28067549-50EF1FE5-D380-4258-9791-D92E4D4E4BEFQ30366102-0CDED0DF-05D9-44A8-8450-E24EB50C5475Q33559128-36EE4087-D66D-4078-87E5-D0FDB8E8776CQ33618285-67B51556-4908-40E3-9701-163A04AEBE74Q33684887-F99F2545-0C7A-407E-9805-A85232F9939FQ33751043-7B309D8C-1314-4EC2-8744-BEF41BF831E7Q36155201-75D1DCE6-1C0A-4EC3-BC9B-E061392AE9F7Q36237785-337C5D1F-AC99-4BCE-877C-30F5663137E8Q36540937-BD4C4F80-C10F-4B29-ADCD-A82BE15249D6Q37295773-0CA440E3-EDD9-42BC-AC35-382240B86E61Q38573871-1825C7C6-7850-4C40-9DCB-6ADE8C51D264Q38631119-8307C7AF-6879-4EAC-B692-D071633D8AE9Q38633382-039BE4FC-5FFC-4642-A30B-CDF382DBE893Q38639962-4688D10C-A438-44AB-8A6D-9AC39B62765FQ38664177-918BE348-5DB9-4CEE-8506-AB345C7E9800Q38704068-31655AED-C784-4705-A1E4-1E29DA889AC2Q38704258-6A854198-B4D2-4E17-98CC-B925B8F8E7FBQ38735156-77BD1D44-F43D-4487-88CF-124A1D62377BQ38742272-644DA07D-0749-44F9-AB12-F9C72CCFA792Q38906201-5EBAAFD6-ED90-4C25-A393-3D134C7E834EQ39438805-345B8C15-AB4F-4EB9-84D2-B9A0A330F6B5Q39473116-867C573E-B780-476A-ACCC-FB41ADF5B0C2Q41225190-D0994FAD-9063-4B87-901E-39C875CA45EDQ41425998-C6EB16BF-81A7-449A-BED7-812441A59069Q47857737-B0F91A26-94AA-43DA-BA68-9CCCA2E3628BQ50199981-8DA0DDC7-F4F2-473B-8C7B-5EEC18E8E8EAQ51115531-011AF099-7197-48D6-9C03-1FA4DDF48181Q55365185-529F9070-6A1B-42A5-BAAD-8E78D06D6477
P2860
TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
TP53 mutations detected in cir ...... gative breast cancer patients.
@ast
TP53 mutations detected in cir ...... gative breast cancer patients.
@en
type
label
TP53 mutations detected in cir ...... gative breast cancer patients.
@ast
TP53 mutations detected in cir ...... gative breast cancer patients.
@en
prefLabel
TP53 mutations detected in cir ...... gative breast cancer patients.
@ast
TP53 mutations detected in cir ...... gative breast cancer patients.
@en
P2093
P2860
P1476
TP53 mutations detected in cir ...... gative breast cancer patients.
@en
P2093
Catherine Bingham
Gary Palmer
Juan Palazzo
Katherine Alpaugh
Laura Austin
Massimo Cristofanilli
Patricia Fittipaldi
Sandra V Fernandez
P2860
P2888
P356
10.1186/S13058-014-0445-3
P577
2014-10-09T00:00:00Z
P5875
P6179
1040823278